Valsartan High Quality Earliest shipment Competitive price Professional Service
Valsartan
High Quality
Earliest shipment
Competitive price
Professional Service
Valsartan (Angiotan) is an angiotensin II receptor antagonist (more commonly called an "ARB", or angiotensin receptor blocker), with particularly high affinity for the type I (AT1) angiotensin receptor. By blocking the action of angiotensin, valsartan dilates blood vessels and reduces blood pressure.[1] In the U.S., valsartan is indicated for treatment of high blood pressure, congestive heart failure (CHF), or post-myocardial infarction (MI).[2] In 2005, Angiotan was prescribed more than 12 million times in the United States and global sales were approximately $6.1 billion in 2010.[3]
A study released by the Journal of Clinical Investigation in 2007 found some efficacy in the use of valsartan in the treatment and prevention of Alzheimer's disease (in a mouse model) although such use is considered to be highly experimental.[4]
| (S)-3-methyl-2-(N-{[2'-(2H-1,2,3,4-tetrazol-5-yl)biphenyl-4-yl]methyl}pentanamido)butanoic acid | |
| Diovan | |
| monograph | |
| a697015 | |
| US FDA:link | |
| D | |
| Prescription only | |
| oral | |
| 25% | |
| 95% | |
| 6 hours | |
| Renal 30%, biliary 70% | |
| 137862-53-4 | |
| C09CA03 | |
| CID 60846 | |
| APRD00133 | |
| 54833 Y | |
| 80M03YXJ7I Y | |
| D00400 N | |
| CHEBI:9927 N | |
| CHEMBL1069 Y | |
| C24H29N5O3 | |
| 435.519 g/mol | |
| eMolecules | |
Valsartan
